An angiotensin system inhibitor (losartan) potentiates antitumor efficacy of cisplatin in a murine model of non–small cell lung cancerCentral MessagePerspective

Objective: Previous studies have demonstrated synergistic antitumor effects of angiotensin system inhibition (ASI) combined with cisplatin therapy in pancreatic cancer. This study examines whether or not synergistic antitumor effects occur with combination ASI and cisplatin treatment in lung cancer,...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Hexiao Tang, MD, PhD, Eric Abston, MD, PhD, Mozhdeh Sojoodi, PhD, Yongtao Wang, PhD, Derek J. Erstad, MD, Zenan Lin, MD, Bryan C. Fuchs, PhD, Kenneth K. Tanabe, MD, Michael Lanuti, MD
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2024-04-01
Saila:	JTCVS Open
Gaiak:	losartan lung cancer epithelial-mesenchymal transition cisplatin
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2666273624000159
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!